Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| MetaVia Inc. | 30,734 | reported | 23 Jan 2026 | tx 5+75,696−17,617 |
| Furiex Pharmaceuticals, Inc. | 16,411 | reported | 10 Jun 2013 | tx 6+129,756 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 23 Jan 2026 | GRANT_AWARD | MetaVia Inc. | 28,000 | 0.00 USD | |
| 12 Aug 2025 | GIFT | MetaVia Inc. | 14,200 | 0.00 USD | |
| 04 Jun 2025 | PURCHASE | MetaVia Inc. | 14,200 | 0.70 USD | first after silence |
| 01 Mar 2025 | TAX_WITHHOLDING | MetaVia Inc. | 3,417 | 1.46 USD | |
| 01 Mar 2024 | GRANT_AWARD | MetaVia Inc. | 33,496 | 0.00 USD | |
| 10 Jun 2013 | GRANT_AWARD | Furiex Pharmaceuticals, Inc. | 10,200 | 0.00 USD | |
| 24 Feb 2012 | GRANT_AWARD | Furiex Pharmaceuticals, Inc. | 8,294 | 0.00 USD | deriv |
| 04 Nov 2011 | PURCHASE | Furiex Pharmaceuticals, Inc. | 6,211 | 14.78 USD | |
| 03 Oct 2011 | GRANT_AWARD | Furiex Pharmaceuticals, Inc. | 29,644 | 0.00 USD | deriv |
| 09 May 2011 | GRANT_AWARD | Furiex Pharmaceuticals, Inc. | 26,000 | 0.00 USD | deriv |
| 17 Jun 2010 | GRANT_AWARD | Furiex Pharmaceuticals, Inc. | 49,407 | 0.00 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 04 Jun 2025.